WOBURN, Mass.--(BUSINESS WIRE)--Feb. 27, 2006--Aphios Corporation today announced that it has been awarded a Japanese patent for its phospholipid nanosomes technology platform. Phospholipid nanosomes are small, uniform liposomes manufactured utilizing SuperFluids(TM). SuperFluids(TM) are normally gases which, when compressed, exhibit enhanced solvation, penetration and expansive properties. These fluids are reverse-engineered to form phospholipid nanosomes for encapsulating and improving the delivery of proteins, peptides and genes as well as small molecule therapeutics. Dr. Castor, the inventor of this technology platform, points out, “This technology does not utilize organic solvents that could be harmful to the product, the recipient and/or the environment and is rapid, broadly-applicable and scalable while enhancing drug delivery.”
